-
1
-
-
20844463069
-
Stability of lentiviral vector-mediated transgene expression in the brain in the presence of systemic antivector immune responses
-
Abordo-Adesida, E., Follenzi, A., Barcia, C., et al. (2005). Stability of lentiviral vector-mediated transgene expression in the brain in the presence of systemic antivector immune responses. Hum. Gene Ther. 16, 741-751.
-
(2005)
Hum. Gene Ther.
, vol.16
, pp. 741-751
-
-
Abordo-Adesida, E.1
Follenzi, A.2
Barcia, C.3
-
2
-
-
84879867061
-
Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott- Aldrich syndrome
-
Aiuti, A., Biasco, L., Scaramuzza, S., et al. (2013). Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott- Aldrich syndrome. Science 341, 1233151.
-
(2013)
Science
, vol.341
, pp. 1233151
-
-
Aiuti, A.1
Biasco, L.2
Scaramuzza, S.3
-
3
-
-
35548987090
-
Stable gene transfer to muscle using non-integrating lentiviral vectors
-
Apolonia, L., Waddington, S.N., Fernandes, C., et al. (2007). Stable gene transfer to muscle using non-integrating lentiviral vectors. Mol. Ther. 15, 1947-1954.
-
(2007)
Mol. Ther.
, vol.15
, pp. 1947-1954
-
-
Apolonia, L.1
Waddington, S.N.2
Fernandes, C.3
-
4
-
-
84867744253
-
Bioinformatical clonality analysis of next generation sequencing derived viral vector integration sites
-
Arens, A., Appelt, J.U., Bartholomae, C., et al. (2012). Bioinformatical clonality analysis of next generation sequencing derived viral vector integration sites. Hum. Gene Ther. Methods. 23, 111-118.
-
(2012)
Hum. Gene Ther. Methods.
, vol.23
, pp. 111-118
-
-
Arens, A.1
Appelt, J.U.2
Bartholomae, C.3
-
5
-
-
76749152709
-
Integrase-defective lentiviral vectors: Progress and applications
-
Banasik, M.B., and McCray, P.B., Jr. (2010). Integrase-defective lentiviral vectors: progress and applications. Gene Ther. 17, 150-157.
-
(2010)
Gene Ther.
, vol.17
, pp. 150-157
-
-
Banasik, M.B.1
McCray Jr., P.B.2
-
6
-
-
79961126259
-
Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: Support for nigral targeting in Parkinson's disease
-
Bartus, R.T., Brown, L., Wilson, A., et al. (2011). Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: support for nigral targeting in Parkinson's disease. Neurobiol. Disease 44, 38-52.
-
(2011)
Neurobiol. Disease
, vol.44
, pp. 38-52
-
-
Bartus, R.T.1
Brown, L.2
Wilson, A.3
-
7
-
-
0033104019
-
Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor
-
Batchelor, P.E., Liberatore, G.T., Wong, J.Y., et al. (1999). Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J. Neurosci. 19, 1708-1716.
-
(1999)
J. Neurosci.
, vol.19
, pp. 1708-1716
-
-
Batchelor, P.E.1
Liberatore, G.T.2
Wong, J.Y.3
-
8
-
-
84859443778
-
Retroviral integrations in gene therapy trials
-
Biasco, L., Baricordi, C., and Aiuti, A. (2012). Retroviral integrations in gene therapy trials. Mol. Ther. 20, 709-716.
-
(2012)
Mol. Ther.
, vol.20
, pp. 709-716
-
-
Biasco, L.1
Baricordi, C.2
Aiuti, A.3
-
9
-
-
79954733266
-
Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection
-
Biffi, A., Bartolomae, C.C., Cesana, D., et al. (2011). Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection. Blood 117, 5332-5339.
-
(2011)
Blood
, vol.117
, pp. 5332-5339
-
-
Biffi, A.1
Bartolomae, C.C.2
Cesana, D.3
-
10
-
-
0034672304
-
Towards a neuroprotective gene therapy for Parkinson's disease: Use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model
-
Bjorklund, A., Kirik, D., Rosenblad, C., et al. (2000). Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model. Brain Res. 886, 82-98.
-
(2000)
Brain Res.
, vol.886
, pp. 82-98
-
-
Bjorklund, A.1
Kirik, D.2
Rosenblad, C.3
-
11
-
-
84860213812
-
Challenges for gene therapy of CNS disorders and implications for Parkinson's disease therapies
-
Broadstock, M., and Yáñez-Muñoz, R.J. (2012). Challenges for gene therapy of CNS disorders and implications for Parkinson's disease therapies. Hum. Gene Ther. 23, 340-343.
-
(2012)
Hum. Gene Ther.
, vol.23
, pp. 340-343
-
-
Broadstock, M.1
Yáñez-Muñoz, R.J.2
-
12
-
-
79851509664
-
Pseudotypedependent lentiviral transduction of astrocytes or neurons in the rat substantia nigra
-
Cannon, J.R., Sew, T., Montero, L., et al. (2011). Pseudotypedependent lentiviral transduction of astrocytes or neurons in the rat substantia nigra. Exp. Neurol. 228, 41-52.
-
(2011)
Exp. Neurol.
, vol.228
, pp. 41-52
-
-
Cannon, J.R.1
Sew, T.2
Montero, L.3
-
13
-
-
13844255766
-
Gene therapy for Parkinson's disease: Progress and challenges
-
Chen, Q., He, Y., and Yang, K. (2005). Gene therapy for Parkinson's disease: progress and challenges. Curr. Gene Ther. 5, 71-80.
-
(2005)
Curr. Gene Ther.
, vol.5
, pp. 71-80
-
-
Chen, Q.1
He, Y.2
Yang, K.3
-
14
-
-
84871250204
-
Integrasedeficient lentiviral vectors mediate efficient gene transfer to human vascular smooth muscle cells with minimal genotoxic risk
-
Chick, H.E., Nowrouzi, A., Fronza, R., et al. (2012). Integrasedeficient lentiviral vectors mediate efficient gene transfer to human vascular smooth muscle cells with minimal genotoxic risk. Hum. Gene Ther. 23, 1247-1257.
-
(2012)
Hum. Gene Ther.
, vol.23
, pp. 1247-1257
-
-
Chick, H.E.1
Nowrouzi, A.2
Fronza, R.3
-
15
-
-
79955628980
-
Anterograde axonal transport of AAV2-GDNF in rat basal ganglia
-
Ciesielska, A., Mittermeyer, G., Hadaczek, P., et al. (2011). Anterograde axonal transport of AAV2-GDNF in rat basal ganglia. Mol. Ther. 19, 922-927.
-
(2011)
Mol. Ther.
, vol.19
, pp. 922-927
-
-
Ciesielska, A.1
Mittermeyer, G.2
Hadaczek, P.3
-
16
-
-
36249015420
-
Gene delivery by lentivirus vectors
-
Cockrell, A.S., and Kafri, T. (2007). Gene delivery by lentivirus vectors. Mol. Biotechnol. 36, 184-204.
-
(2007)
Mol. Biotechnol.
, vol.36
, pp. 184-204
-
-
Cockrell, A.S.1
Kafri, T.2
-
17
-
-
78651367197
-
Effects of intrastriatal GDNF on the response of dopamine neurons to 6-hydroxydopamine: Time course of protection and neurorestoration
-
Cohen, A.D., Zigmond, M.J., and Smith, A.D. (2011). Effects of intrastriatal GDNF on the response of dopamine neurons to 6-hydroxydopamine: time course of protection and neurorestoration. Brain Res. 1370, 80-88.
-
(2011)
Brain Res.
, vol.1370
, pp. 80-88
-
-
Cohen, A.D.1
Zigmond, M.J.2
Smith, A.D.3
-
18
-
-
84891836253
-
Transduction of fetal mice with a feline lentiviral vector induces liver tumors which exhibit an E2F activation signature
-
Condiotti, R., Goldenberg, D., Giladi, H., et al. (2013). Transduction of fetal mice with a feline lentiviral vector induces liver tumors which exhibit an E2F activation signature. Mol. Ther. 22, 59-68.
-
(2013)
Mol. Ther.
, vol.22
, pp. 59-68
-
-
Condiotti, R.1
Goldenberg, D.2
Giladi, H.3
-
19
-
-
84857782774
-
Efficient gene therapy for Parkinson's disease using astrocytes as hosts for localized neurotrophic factor delivery
-
Drinkut, A., Tereshchenko, Y., Schulz, J.B., et al. (2012). Efficient gene therapy for Parkinson's disease using astrocytes as hosts for localized neurotrophic factor delivery. Mol. Ther. 20, 534-543.
-
(2012)
Mol. Ther.
, vol.20
, pp. 534-543
-
-
Drinkut, A.1
Tereshchenko, Y.2
Schulz, J.B.3
-
20
-
-
0031710033
-
A third-generation lentivirus vector with a conditional packaging system
-
Dull, T., Zufferey, R., Kelly, M., et al. (1998). A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72, 8463-8471.
-
(1998)
J. Virol.
, vol.72
, pp. 8463-8471
-
-
Dull, T.1
Zufferey, R.2
Kelly, M.3
-
21
-
-
0345257314
-
Recombinant adeno-associated viral vector (rAAV) delivery of GDNF provides protection against 6-OHDA lesion in the common marmoset monkey (Callithrix jacchus)
-
Eslamboli, A., Cummings, R.M., Ridley, R.M., et al. (2003). Recombinant adeno-associated viral vector (rAAV) delivery of GDNF provides protection against 6-OHDA lesion in the common marmoset monkey (Callithrix jacchus). Exp. Neurol. 184, 536-548.
-
(2003)
Exp. Neurol.
, vol.184
, pp. 536-548
-
-
Eslamboli, A.1
Cummings, R.M.2
Ridley, R.M.3
-
22
-
-
3242762057
-
Overexpression of glial cell line-derived neurotrophic factor using a lentiviral vector induces time- and dose-dependent downregulation of tyrosine hydroxylase in the intact nigrostriatal dopamine system
-
Georgievska, B., Kirik, D., and Bjorklund, A. (2004). Overexpression of glial cell line-derived neurotrophic factor using a lentiviral vector induces time- and dose-dependent downregulation of tyrosine hydroxylase in the intact nigrostriatal dopamine system. J. Neurosci. 24, 6437-6445.
-
(2004)
J. Neurosci.
, vol.24
, pp. 6437-6445
-
-
Georgievska, B.1
Kirik, D.2
Bjorklund, A.3
-
23
-
-
0038249170
-
Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease
-
Gill, S.S., Patel, N.K., Hotton, G.R., et al. (2003). Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat. Med. 9, 589-595.
-
(2003)
Nat. Med.
, vol.9
, pp. 589-595
-
-
Gill, S.S.1
Patel, N.K.2
Hotton, G.R.3
-
24
-
-
0037448352
-
A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency
-
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., et al. (2003). A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348, 255-256.
-
(2003)
N. Engl. J. Med.
, vol.348
, pp. 255-256
-
-
Hacein-Bey-Abina, S.1
Von Kalle, C.2
Schmidt, M.3
-
25
-
-
0018894295
-
Circling behavior in rats with partial, unilateral nigrostriatal lesions: Effect of amphetamine, apomorphine, and DOPA
-
Hefti, F., Melamed, E., Sahakian, B.J., and Wurtman, R.J. (1980). Circling behavior in rats with partial, unilateral nigrostriatal lesions: effect of amphetamine, apomorphine, and DOPA. Pharmacol. Biochem. Behav. 12, 185-188.
-
(1980)
Pharmacol. Biochem. Behav.
, vol.12
, pp. 185-188
-
-
Hefti, F.1
Melamed, E.2
Sahakian, B.J.3
Wurtman, R.J.4
-
26
-
-
34249067496
-
Efficient gene transduction of neurons by lentivirus with enhanced neuron-specific promoters
-
Hioki, H., Kameda, H., Nakamura, H., et al. (2007). Efficient gene transduction of neurons by lentivirus with enhanced neuron-specific promoters. Gene Ther. 14, 872-882.
-
(2007)
Gene Ther.
, vol.14
, pp. 872-882
-
-
Hioki, H.1
Kameda, H.2
Nakamura, H.3
-
27
-
-
84855453499
-
Corticospinal tract transduction: A comparison of seven adeno-associated viral vector serotypes and a non-integrating lentiviral vector
-
Hutson, T.H., Verhaagen, J., Yáñez-Muñoz, R.J., and Moon, L.D. (2012). Corticospinal tract transduction: a comparison of seven adeno-associated viral vector serotypes and a non-integrating lentiviral vector. Gene Ther. 19, 49-60.
-
(2012)
Gene Ther.
, vol.19
, pp. 49-60
-
-
Hutson, T.H.1
Verhaagen, J.2
Yáñez-Muñoz, R.J.3
Moon, L.D.4
-
28
-
-
32944473438
-
Lentiviral vectors for use in the central nervous system
-
Jakobsson, J., and Lundberg, C. (2006). Lentiviral vectors for use in the central nervous system. Mol. Ther. 13, 484-493.
-
(2006)
Mol. Ther.
, vol.13
, pp. 484-493
-
-
Jakobsson, J.1
Lundberg, C.2
-
29
-
-
0041336901
-
Targeted transgene expression in rat brain using lentiviral vectors
-
Jakobsson, J., Ericson, C., Jansson, M., et al. (2003). Targeted transgene expression in rat brain using lentiviral vectors. J. Neurosci. Res. 73, 876-885.
-
(2003)
J. Neurosci. Res.
, vol.73
, pp. 876-885
-
-
Jakobsson, J.1
Ericson, C.2
Jansson, M.3
-
30
-
-
0033773237
-
Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor
-
Kirik, D., Rosenblad, C., and Bjorklund, A. (2000). Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor. Eur. J. Neurosci. 12, 3871-3882.
-
(2000)
Eur. J. Neurosci.
, vol.12
, pp. 3871-3882
-
-
Kirik, D.1
Rosenblad, C.2
Bjorklund, A.3
-
31
-
-
33644833272
-
Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease
-
Lang, A.E., Gill, S., Patel, N.K., et al. (2006). Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease. Ann. Neurol. 59, 459-466.
-
(2006)
Ann. Neurol.
, vol.59
, pp. 459-466
-
-
Lang, A.E.1
Gill, S.2
Patel, N.K.3
-
32
-
-
77952541168
-
Optimal promoter usage for lentiviral vector-mediated transduction of cultured central nervous system cells
-
Li, M., Husic, N., Lin, Y., et al. (2010). Optimal promoter usage for lentiviral vector-mediated transduction of cultured central nervous system cells. J. Neurosci. Methods 189, 56-64.
-
(2010)
J. Neurosci. Methods
, vol.189
, pp. 56-64
-
-
Li, M.1
Husic, N.2
Lin, Y.3
-
33
-
-
0027285510
-
GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons
-
Lin, L.F., Doherty, D.H., Lile, J.D., et al. (1993). GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260, 1130-1132.
-
(1993)
Science
, vol.260
, pp. 1130-1132
-
-
Lin, L.F.1
Doherty, D.H.2
Lile, J.D.3
-
34
-
-
80155177681
-
Diagnosis and initiation of treatment in Parkinson's disease
-
Lyons, K.E., and Pahwa, R. (2011). Diagnosis and initiation of treatment in Parkinson's disease. Int. J. Neurosci. 121 Suppl 2, 27-36.
-
(2011)
Int. J. Neurosci.
, vol.121 SUPPL. 2
, pp. 27-36
-
-
Lyons, K.E.1
Pahwa, R.2
-
35
-
-
41949110690
-
Safety and tolerability of intraputaminal delivery of CERE- 120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: An open-label, phase i trial
-
Marks, W.J., Jr., Ostrem, J.L., Verhagen, L., et al. (2008). Safety and tolerability of intraputaminal delivery of CERE- 120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial. Lancet Neurol. 7, 400-408.
-
(2008)
Lancet Neurol.
, vol.7
, pp. 400-408
-
-
Marks Jr., W.J.1
Ostrem, J.L.2
Verhagen, L.3
-
36
-
-
78349247631
-
Gene delivery of AAV2-neurturin for Parkinson's disease: A double- blind, randomised, controlled trial
-
Marks, W.J., Jr., Bartus, R.T., Siffert, J., et al. (2010). Gene delivery of AAV2-neurturin for Parkinson's disease: a double- blind, randomised, controlled trial. Lancet Neurol. 9, 1164-1172.
-
(2010)
Lancet Neurol.
, vol.9
, pp. 1164-1172
-
-
Marks Jr., W.J.1
Bartus, R.T.2
Siffert, J.3
-
37
-
-
77649273815
-
Recent advances in lentiviral vector development and applications
-
Mátrai, J., Chuah, M.K., and Vandendriessche, T. (2010). Recent advances in lentiviral vector development and applications. Mol. Ther. 18, 477-490.
-
(2010)
Mol. Ther.
, vol.18
, pp. 477-490
-
-
Mátrai, J.1
Chuah, M.K.2
Vandendriessche, T.3
-
38
-
-
79955114567
-
Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk
-
Mátrai, J., Cantore, A., Bartholomae, C.C., et al. (2011). Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk. Hepatology 53, 1696-1707.
-
(2011)
Hepatology
, vol.53
, pp. 1696-1707
-
-
Mátrai, J.1
Cantore, A.2
Bartholomae, C.C.3
-
39
-
-
0032738677
-
The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease
-
Mirza, B., Hadberg, H., Thomsen, P., and Moos, T. (2000). The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease. Neuroscience 95, 425-432.
-
(2000)
Neuroscience
, vol.95
, pp. 425-432
-
-
Mirza, B.1
Hadberg, H.2
Thomsen, P.3
Moos, T.4
-
40
-
-
0035896463
-
Glial cell linederived neurotrophic factor in the substantia nigra from control and parkinsonian brains
-
Mogi, M., Togari, A., Kondo, T., et al. (2001). Glial cell linederived neurotrophic factor in the substantia nigra from control and parkinsonian brains. Neurosci. Lett. 300, 179-181.
-
(2001)
Neurosci. Lett.
, vol.300
, pp. 179-181
-
-
Mogi, M.1
Togari, A.2
Kondo, T.3
-
41
-
-
84873391456
-
The fetal mouse is a sensitive genotoxicity model that exposes lentiviralassociated mutagenesis resulting in liver oncogenesis
-
Nowrouzi, A., Cheung, W.T., Li, T., et al. (2013). The fetal mouse is a sensitive genotoxicity model that exposes lentiviralassociated mutagenesis resulting in liver oncogenesis. Mol. Ther. 21, 324-337.
-
(2013)
Mol. Ther.
, vol.21
, pp. 324-337
-
-
Nowrouzi, A.1
Cheung, W.T.2
Li, T.3
-
42
-
-
77955220225
-
Genomewide high-throughput integrome analyses by nrLAM-PCR and next-generation sequencing
-
Paruzynski, A., Arens, A., Gabriel, R., et al. (2010). Genomewide high-throughput integrome analyses by nrLAM-PCR and next-generation sequencing. Nat. Protoc. 5, 1379-1395.
-
(2010)
Nat. Protoc.
, vol.5
, pp. 1379-1395
-
-
Paruzynski, A.1
Arens, A.2
Gabriel, R.3
-
43
-
-
46049095244
-
Absolute requirement of GDNF for adult catecholaminergic neuron survival
-
Pascual, A., Hidalgo-Figueroa, M., Piruat, J.I., et al. (2008). Absolute requirement of GDNF for adult catecholaminergic neuron survival. Nat. Neurosci. 11, 755-761.
-
(2008)
Nat. Neurosci.
, vol.11
, pp. 755-761
-
-
Pascual, A.1
Hidalgo-Figueroa, M.2
Piruat, J.I.3
-
44
-
-
84882273865
-
Efficient gene expression from integration-deficient lentiviral vectors in the spinal cord
-
Peluffo, H., Foster, E., Ahmed, S.G., et al. (2013). Efficient gene expression from integration-deficient lentiviral vectors in the spinal cord. Gene Ther. 20, 645-657.
-
(2013)
Gene Ther.
, vol.20
, pp. 645-657
-
-
Peluffo, H.1
Foster, E.2
Ahmed, S.G.3
-
45
-
-
33845187432
-
Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo
-
Philippe, S., Sarkis, C., Barkats, M., et al. (2006). Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo. Proc. Natl. Acad. Sci. USA 103, 17684-17689.
-
(2006)
Proc. Natl. Acad. Sci. USA
, vol.103
, pp. 17684-17689
-
-
Philippe, S.1
Sarkis, C.2
Barkats, M.3
-
46
-
-
64549111301
-
Efficient gene delivery to the adult and fetal CNS using pseudotyped non-integrating lentiviral vectors
-
Rahim, A.A., Wong, A.M., Howe, S.J., et al. (2009). Efficient gene delivery to the adult and fetal CNS using pseudotyped non-integrating lentiviral vectors. Gene Ther. 16, 509-520.
-
(2009)
Gene Ther.
, vol.16
, pp. 509-520
-
-
Rahim, A.A.1
Wong, A.M.2
Howe, S.J.3
-
47
-
-
79957889890
-
Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson's disease
-
Richardson, R.M., Kells, A.P., Rosenbluth, K.H., et al. (2011). Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson's disease. Mol. Ther. 19, 1048-1057.
-
(2011)
Mol. Ther.
, vol.19
, pp. 1048-1057
-
-
Richardson, R.M.1
Kells, A.P.2
Rosenbluth, K.H.3
-
48
-
-
55049090172
-
Driving GDNF expression: The green and the red traffic lights
-
Saavedra, A., Baltazar, G., and Duarte, E.P. (2008). Driving GDNF expression: the green and the red traffic lights. Prog. Neurobiol. 86, 186-215.
-
(2008)
Prog. Neurobiol.
, vol.86
, pp. 186-215
-
-
Saavedra, A.1
Baltazar, G.2
Duarte, E.P.3
-
49
-
-
36749052217
-
High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM-PCR)
-
Schmidt, M., Schwarzwaelder, K., Bartholomae, C., et al. (2007). High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM-PCR). Nat. Methods 4, 1051-1057.
-
(2007)
Nat. Methods
, vol.4
, pp. 1051-1057
-
-
Schmidt, M.1
Schwarzwaelder, K.2
Bartholomae, C.3
-
50
-
-
0037479840
-
Changes in function and ultrastructure of striatal dopaminergic terminals that regenerate following partial lesions of the SNpc
-
Stanic, D., Parish, C.L., Zhu, W.M., et al. (2003). Changes in function and ultrastructure of striatal dopaminergic terminals that regenerate following partial lesions of the SNpc. J. Neurochem. 86, 329-343.
-
(2003)
J. Neurochem.
, vol.86
, pp. 329-343
-
-
Stanic, D.1
Parish, C.L.2
Zhu, W.M.3
-
51
-
-
23844507993
-
Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice
-
Themis, M., Waddington, S.N., Schmidt, M., et al. (2005). Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice. Mol. Ther. 12, 763-771.
-
(2005)
Mol. Ther.
, vol.12
, pp. 763-771
-
-
Themis, M.1
Waddington, S.N.2
Schmidt, M.3
-
52
-
-
0029114190
-
Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult
-
Tomac, A., Widenfalk, J., Lin, L.F., et al. (1995). Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult. Proc. Natl. Acad. Sci. USA 92, 8274-8278.
-
(1995)
Proc. Natl. Acad. Sci. USA
, vol.92
, pp. 8274-8278
-
-
Tomac, A.1
Widenfalk, J.2
Lin, L.F.3
-
53
-
-
0036708174
-
Gene transfer of glial cell-derived neurotrophic factor and cardiotrophin-1 protects PC12 cells from injury: Involvement of the phosphatidylinositol 3-kinase and mitogen-activated protein kinase kinase pathways
-
Toth, G., Yang, H., Anguelov, R.A., et al. (2002). Gene transfer of glial cell-derived neurotrophic factor and cardiotrophin-1 protects PC12 cells from injury: involvement of the phosphatidylinositol 3-kinase and mitogen-activated protein kinase kinase pathways. J.Neurosci. Res. 69, 622-632.
-
(2002)
J.Neurosci. Res.
, vol.69
, pp. 622-632
-
-
Toth, G.1
Yang, H.2
Anguelov, R.A.3
-
54
-
-
68249112926
-
Integrationdeficient lentiviral vectors: A slow coming of age
-
Wanisch, K., and Yáñez-Muñoz, R.J. (2009). Integrationdeficient lentiviral vectors: a slow coming of age. Mol. Ther. 17, 1316-1332.
-
(2009)
Mol. Ther.
, vol.17
, pp. 1316-1332
-
-
Wanisch, K.1
Yáñez-Muñoz, R.J.2
-
55
-
-
33644822908
-
Effective gene therapy with nonintegrating lentiviral vectors
-
Yáñez-Muñoz, R.J., Balaggan, K.S., Macneil, A., et al. (2006). Effective gene therapy with nonintegrating lentiviral vectors. Nat. Med. 12, 348-353.
-
(2006)
Nat. Med.
, vol.12
, pp. 348-353
-
-
Yáñez-Muñoz, R.J.1
Balaggan, K.S.2
Macneil, A.3
|